1. Silber MH, Ehrenberg BL, Allen RP, Buchfuhrer MJ, Earley CJ, Hening WA, Rye DB, Medical Advisory Board of the Restless Legs Syndrome Foundation. An algorithm for the management of restless legs syndrome. Mayo Clin Proc. 2004;79(7):916–22.
2. Bliwise DL, Zhang RH, Kutner NG. Medications aasociated with restless legs syndrome: a case-control study in the US renal data system (USRDS). Sleep Med. 2014;15(10):1241–5.
3. Yanai K, Ryu JH, Watanabe T, Iwata R, Ido T, Sawai Y, Ito K, Itoh M. Histamine H1 receptor occupancy in human brains after single oral doses of histamine H1 antagonists measured by positron emission tomography. Br J Pharmacol. 1995;116(1):1649–55.
4. Mann RD, Pearce GL, Dunn N, Shakir S. Sedation with “non-sedating” antihistamines: four prescription-event monitoring studies in general practice. BMJ. 2000;320(7243):1184–7.
5. Allen RP, Lesage S, Earley CJ. Anti-histamines and benzodiazepines exacerbate daytime restless legs syndrome symptoms [abstract]. Sleep. 2005;28:A279.